Skip to main content

Volume 2 Supplement 3

Abstracts of the 29th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC)

  • Poster presentation
  • Open access
  • Published:

Liver sulfatide-reactive type II NKT cells recognize endogenous phospholipids

NKT cells are a unique population of T cells that recognize lipid antigens presented by a nonclassical MHC-like molecule CD1d. There are two types of NKT cells, type I and type II. Our group previously showed that type I NKT cells enhance and type II NKT cells suppress anti-tumor responses, and that these two types of NKT cells cross-regulate each other. One of the defined antigens for type I NKT cells is alpha-galactosylceramide (aGC), and aGC-loaded CD1d tetramers are widely used to study them. Unlike conventional T cells, each subset of NKT cells recognizes distinct antigens. Sulfatide (3-o-sulfo-beta-D-galactosylceramide), an endogenous lipid, is the only lipid proven to be recognized by type II NKT cells in vivo. In addition, recently phosphatidylglycerol (PG) and phosphatidylinositol (PI), also endogenous lipids, were reported to be recognized by type II NKT cell hybridomas. So far, type II NKT cells and their antigens are much less well characterized than type I due to lack of widely available tools to study them. Our laboratory had developed a new method to create sulfatide-loaded CD1d tetramers, which could identify type II NKT cells. In this study, we compared phospholipid-reactive type II NKT cells and sulfatide-reactive type II NKT cells. PG-or PI-loaded CD1d-tetramer-reactive NKT cells were observed in liver mononuclear cells, and they were distinct populations from aGC-loaded CD1d-tetramer-reactive cells, indicating that there were PG- and PI-reactive type II NKT cells. Simultaneous staining with PG-, PI-, and sulfatide-loaded CD1d-tetramers indicated, surprisingly, that these three populations were largely identical, even though the phospholipids have structures quite distinct from that of sulfatide. For functional studies, the effect of these lipid antigens in cytokine production and regulating anti-tumor immunity was tested. IFN-gamma and IL-4 production by spleen cells was detected after stimulation with sulfatide in vitro, but not with PG or PI. In the murine colon cancer cell line CT26 lung metastases model, the anti-tumor response induced by aGC was reduced by simultaneous injection of sulfatide. In contrast, PG injection didn't affect the anti-tumor response induced by aGC. These findings suggest that although PG and PI, when loaded onto CD1d, bind the same cells as do sulfatide-CD1d tetramers, their function in vitro and in vivo was distinct. Now we are further examining the activities of these phospholipids on type II NKT cells.

Author information

Authors and Affiliations

Authors

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kato, S., Terabe, M. & Berzofsky, J.A. Liver sulfatide-reactive type II NKT cells recognize endogenous phospholipids. j. immunotherapy cancer 2 (Suppl 3), P215 (2014). https://doi.org/10.1186/2051-1426-2-S3-P215

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/2051-1426-2-S3-P215

Keywords